Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 1, 2014, Pages 5-11

  Russell, K L ^a   Berman, N E J ^a   Gregg, P R A ^a   Levant, B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Fish oil; Juvenile; Matrix metalloproteinase 9; Rat; Traumatic brain injury

Indexed keywords

DOCOSAPENTAENOIC ACID; FISH OIL; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN G; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPID; SOYBEAN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION; HINDLIMB; INJURY SEVERITY; LIPID COMPOSITION; MALE; MMP9 GENE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; WALKING;

GLYCINE MAX; RATTUS;

BLOOD-BRAIN BARRIER; FISH OIL; JUVENILE; MATRIX METALLOPROTEINASE 9; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; FISH OILS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 9; RATS; RATS, LONG-EVANS; WALKING;

EID: 84891153816     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.11.003     Document Type: Article

References (71)

1. Faul M., Xu L., Wald M., Coronado V. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006, Atlanta (GA): Centers for Disease Control and Prevention 2010, National Center for Injury Prevention and Control.
2. Giza C.C., Prins M.L. Is being plastic fantastic? mechanisms of altered plasticity after developmental traumatic brain injury. Dev. Neurosci. 2006, 28:364-379.
3. Conroy S., McIntyre J., Choonara I., Stephenson T. Drug trials in children: problems and the way forward. Br. J. Clin. Pharmacol. 2000, 49:93-97.
4. Kearns G.L., Abdel-Rahman S.M., Alander S.W., Blowey D.L., Leeder J.S., Kauffman R.E. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 2003, 349:1157-1167.
5. Prins M.L., Hovda D.A. Developing experimental models to address traumatic brain injury in children. J. Neurotrauma. 2003, 20:123-137.
6. Salem N., Litman B., Kim H.Y., Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36:945-959.
7. Shaikh S.R. Biophysical and biochemical mechanisms by which dietary n-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts. J. Nutr. Biochem. 2012, 23:101-105.
8. Hogyes E., Nyakas C., Kiliaan A., Farkas T., Penke B., Luiten P.G. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience 2003, 119:999-1012.
9. Hossain M.S., Hashimoto M., Masumura S. Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. Neurosci Lett. 1998, 244:157-160.
10. Sinha R.A., Khare P., Rai A., Maurya S.K., Pathak A., Mohan V., Nagar G.K., Mudiam M.K., Godbole M.M., Bandyopadhyay S. Anti-apoptotic role of omega-3-fatty acids in developing brain: perinatal hypothyroid rat cerebellum as apoptotic model. Int. J. Dev. Neurosci. 2009, 27:377-383.
11. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., Fifre A., Sponne I., Leininger-Muller B., Olivier J.L., Pillot T., Oster T. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J. Neurochem. 2006, 96:385-395.
12. Bazan N.G., Marcheselli V.L., Cole-Edwards K. Brain response to injury and neurodegeneration: Endogenous neuroprotective signaling. Ann. NY. Acad. Sci. 2005, 1053:137-147.
13. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Extrauterine fatty acid accretion in infant brain: Implications for fatty acid requirements. Early Hum. Dev. 1980, 4:131-138.
14. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements. Early Hum. Dev. 1980, 4:121-129.
15. Green P., Yavin E. Fatty acid composition of late embryonic and early postnatal rat brain. Lipids 1996, 31:859-865.
16. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
17. Serhan C.N., Yang R., Martinod K., Kasuga K., Pillai P.S., Porter T.F., Oh S.F., Spite M. Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 2009, 206:15-23.
18. Bazan N.G. Neuroprotectin d1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and alzheimer's disease. J. Lipid. Res. 2009, (Suppl 50):S400-405.
19. Khan S.A., Vanden Heuvel J.P. Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J. Nutr. Biochem. 2003, 14:554-567.
20. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: A positive modulator of akt signaling in neuronal survival. Proc. Natl. Acad. Sci. USA 2005, 102:10858-10863.
21. Draper E., Reynolds C.M., Canavan M., Mills K.H., Loscher C.E., Roche H.M. Omega-3 fatty acids attenuate dendritic cell function via nf-kappab independent of ppar gamma. J. Nutr. Biochem. 2011, 22:784-790.
22. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: The components of a model for transport. J. Mol. Neurosci. 2001, 16:181-193. (Discussion 215-121).
23. Mills J.D., Hadley K., Bailes J.E. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery 2011, 68:474-481. (Discussion 481).
24. Pan H.C., Kao T.K., Ou Y.C., Yang D.Y., Yen Y.J., Wang C.C., Chuang Y.H., Liao S.L., Raung S.L., Wu C.W., Chiang A.N., Chen C.J. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J. Nutr. Biochem. 2009, 20:715-725.
25. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., Michael-Titus A.T. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 2006, 26:4672-4680.
26. Lewis M., Ghassemi P., Hibbeln J. Therapeutic use of omega-3 fatty acids in severe head trauma. Am. J. Emerg. Med. 2013, 31(273):e275-278.
27. Levant B., Ozias M.K., Jones K.A., Carlson S.E. Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain. Lipids 2006, 41:407-414.
28. Russell K.L., Berman N.E., Levant B. Low brain dha content worsens sensorimotor outcomes after tbi and decreases tbi-induced timp1 expression in juvenile rats. Prostaglandins Leukot. Essent. Fatty Acids 2013, 89:97-105.
29. Russell K.L., Kutchko K.M., Fowler S.C., Berman N.E., Levant B. Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences. J. Neurosci. Methods 2011, 199:214-222.
30. Onyszchuk G., Al-Hafez B., He Y.Y., Bilgen M., Berman N.E., Brooks W.M. A mouse model of sensorimotor controlled cortical impact: characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology. J. Neurosci. Methods 2007, 160:187-196.
31. Sherwood N.M., Timiras P.S. A Stereotaxic Atlas of the Developing Rat Brain 1970, University of California Press, Ltd, Berkeley and Los Angeles.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Inc., San Diego.
33. Cole J.T., Yarnell A., Kean W.S., Gold E., Lewis B., Ren M., McMullen D.C., Jacobowitz D.M., Pollard H.B., O'Neill J.T., Grunberg N.E., Dalgard C.L., Frank J.A., Watson W.D. Craniotomy: True sham for traumatic brain injury, or a sham of a sham?. J. Neurotrauma 2011, 28:359-369.
34. Stokely M.E., Orr E.L. Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J. Neurotrauma 2008, 25:52-61.
35. Wu J.C., Chen K.Y., Yo Y.W., Huang S.W., Shih H.M., Chiu W.T., Chiang Y.H., Shiau C.Y. Different sham procedures for rats in traumatic brain injury experiments induce corresponding increases in levels of trauma markers. J. Surg. Res. 2013, 179:138-144.
36. Schumacher M.A., Basbaum A.I., Way W.L. Opioid analgesics and antagonists. Basic and Clinical Pharmacology 2012, 543-565. McGraw Hill Lange, New York. B.G. Katzung, S.B. Masters, A.J. Trevor (Eds.).
37. W.S. Rasband, Imagej. 1997-2012, Available from:. http://imagej.nih.gov/ij/.
38. Ye J., Coulouris G., Zaretskaya I., Cutcutache I., Rozen S., Madden T. Primer-blast: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinf. 2012, 13:134.
39. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods 2001, 25:402-408.
40. Harris J.L., Reeves T.M., Phillips L.L. Injury modality, survival interval, and sample region are critical determinants of qrt-pcr reference gene selection during long-term recovery from brain trauma. J. Neurotrauma 2009, 26:1669-1681.
41. Hamm R.J. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J. Neurotrauma 2001, 18:1207-1216.
42. Mills J.D., Bailes J.E., Sedney C.L., Hutchins H., Sears B. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J. Neurosurg. 2011, 114:77-84.
43. Javierre C., Vidal J., Segura R., Lizarraga M.A., Medina J., Ventura J.L. The effect of supplementation with n-3 fatty acids on the physical performance in subjects with spinal cord injury. J. Physiol. Biochem. 2006, 62:271-279.
44. Shin S.S., Dixon C.E. Oral fish oil restores striatal dopamine release after traumatic brain injury. Neurosci. Lett. 2011, 496:168-171.
45. Altman J., Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim. Behav. 1975, 23:896-920.
46. Westerga J., Gramsbergen A. The development of locomotion in the rat. Brain. Res. Dev. Brain. Res. 1990, 57:163-174.
47. Semple B.D., Bye N., Rancan M., Ziebell J.M., Morganti-Kossmann M.C. Role of ccl2 (mcp-1) in traumatic brain injury (tbi): evidence from severe tbi patients and ccl2-/- mice. J. Cereb. Blood. Flow. Metab. 2010, 30:769-782.
48. Laird M.D., Vender J.R., Dhandapani K.M. Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 2008, 16:154-164.
49. Werner C., Engelhard K. Pathophysiology of traumatic brain injury. Br. J. Anaesth. 2007, 99:4-9.
50. Onyszchuk G., He Y.Y., Berman N.E., Brooks W.M. Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J. Neurotrauma 2008, 25:153-171.
51. Aihara N., Tanno H., Hall J.J., Pitts L.H., Noble L.J. Immunocytochemical localization of immunoglobulins in the rat brain: relationship to the blood-brain barrier. J. Comp. Neurol. 1994, 342:481-496.
52. Seitz R.J., Heininger K., Schwendemann G., Toyka K.V., Wechsler W. The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system. Acta Neuropathol. 1985, 68:15-21.
53. Homayoun P., Parkins N.E., Soblosky J., Carey M.E., Rodriguez de Turco E.B., Bazan N.G. Cortical impact injury in rats promotes a rapid and sustained increase in polyunsaturated free fatty acids and diacylglycerols. Neurochem. Res. 2000, 25:269-276.
54. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize bdnf levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
55. Wu A., Ying Z., Gomez-Pinilla F. Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J. Neurotrauma 2007, 24:1587-1595.
56. Wu A., Ying Z., Gomez-Pinilla F. The salutary effects of dha dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J. Neurotrauma 2011, 28:2113-2122.
57. Bailes J.E., Mills J.D. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma 2010, 27:1617-1624.
58. Belayev L., Khoutorova L., Atkins K.D., Bazan N.G. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 2009, 40:3121-3126.
59. Eady T.N., Belayev L., Khoutorova L., Atkins K.D., Zhang C., Bazan N.G. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. PLoS One 2012, 7:e46151.
60. L. Shinto, G. Marracci, L. Bumgarner, V. Yadav, The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: Implications for multiple sclerosis, Autoimmune Dis. 2011 (2011) 134592.
61. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
62. Sifringer M., Stefovska V., Zentner I., Hansen B., Stepulak A., Knaute C., Marzahn J., Ikonomidou C. The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol. Dis. 2007, 25:526-535.
63. Shigemori Y., Katayama Y., Mori T., Maeda T., Kawamata T. Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir. Suppl. 2006, 96:130-133.
64. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J.C., Kawase M., Massengale J., Chan P.H. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 1999, 19:1020-1028.
65. Svedin P., Hagberg H., Savman K., Zhu C., Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J. Neurosci. 2007, 27:1511-1518.
66. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001, 21:7724-7732.
67. Harkness K.A., Adamson P., Sussman J.D., Davies-Jones G.A., Greenwood J., Woodroofe M.N. Dexamethasone regulation of matrix metalloproteinase expression in cns vascular endothelium. Brain 2000, 123(Pt 4):698-709.
68. Lohmann C., Krischke M., Wegener J., Galla H.J. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain. Res. 2004, 995:184-196.
69. Ogawa K., Chen F., Kuang C., Chen Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappab site. Biochem. J. 2004, 381:413-422.
70. Zuniga J., Cancino M., Medina F., Varela P., Vargas R., Tapia G., Videla L.A., Fernandez V. N-3 pufa supplementation triggers ppar-alpha activation and ppar-alpha/nf-kappab interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One 2011, 6:e28502.
71. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., Espat N.J. Nf-kappaB inhibition by omega -3 fatty acids modulates lps-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. Lung Cell. Mol. Physio 2003, 284:L84-89.